| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -1.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GRCE returned -32.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -37.0% |
| 1 year | -32.9% |
| 5 years | -86.4% |
| 10 years | -96.6% |
| All-time high | $1,934.40 (Jul 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GRCE would be worth today ›No. Grace Therapeutics, Inc. has not paid a dividend in the past 12 months.
Grace Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol GRCE.
Grace Therapeutics, Inc. is part of the Healthcare sector.
Grace Therapeutics, Inc. has a market cap of 45.86M USD, based on the latest quote.
